APA (7th ed.) Citation

I, L., A, B., T, V., M, D., F, C., E, H., . . . G, L. (2007). Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: A randomised controlled trial. Lancet, 370(9587), 580. https://doi.org/10.1016/s0140-6736(07)61297-5

Chicago Style (17th ed.) Citation

I, Leroux-Roels, Borkowski A, Vanwolleghem T, Dramé M, Clement F, Hons E, Devaster JM, and Leroux-Roels G. "Antigen Sparing and Cross-reactive Immunity with an Adjuvanted RH5N1 Prototype Pandemic Influenza Vaccine: A Randomised Controlled Trial." Lancet 370, no. 9587 (2007): 580. https://doi.org/10.1016/s0140-6736(07)61297-5.

MLA (9th ed.) Citation

I, Leroux-Roels, et al. "Antigen Sparing and Cross-reactive Immunity with an Adjuvanted RH5N1 Prototype Pandemic Influenza Vaccine: A Randomised Controlled Trial." Lancet, vol. 370, no. 9587, 2007, p. 580, https://doi.org/10.1016/s0140-6736(07)61297-5.